&nbsp;

FrequentlyAskedQuestions-OCRSEERStat13.pdf

Jun 2023

Fumika Test Page

Follow-Up of Self-Collected Human Papillomavirus (HPV) Testing

Document

FITKitInstructions-Slovak.pdf

Dec 2023

Document

FITKitInstructions-Dari.pdf

Dec 2023

Document

FITKitInstructions-Pashto.pdf

Dec 2023

Regimen

GLOF; GLOF(RAMP)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Funding:

New Drug Funding Program

Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

High Cost Therapy Funding Program

Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

Drugs Used:

oBINutuzumab,

glofitamab

Quick Link(s):

Regimen Monograph

Aug 2025

Guidelines and Advice

Fear of Cancer Recurrence Guideline

Status: Current
ID: GL 19-7

Mar 2024

Regimen

GEMC+PEMB(MNT)

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

Drugs Used:

pembrolizumab,

gemcitabine

Quick Link(s):

Regimen Monograph

Dec 2024

Fumika Test Page (FR)

This is FR page

Regimen

FLAG+IDA+VENE

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Curative

Funding:

ODB - General Benefit

filgrastim (biosimilars) - refer to ODB Formulary for details

Drugs Used:

venetoclax (Unfunded)

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

GEMC+RAMU

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Drugs Used:

ramucirumab (Unfunded),

gemcitabine